MediWound Ltd.
MDWD
$13.56
$0.030.22%
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -1.41% | -21.01% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -1.41% | -21.01% | |
| Cost of Revenue | -- | -- | -7.29% | 23.81% | |
| Gross Profit | -- | -- | 37.13% | -77.76% | |
| SG&A Expenses | -- | -- | 22.69% | 1.26% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | 200.00% | |
| Total Operating Expenses | -- | -- | 18.29% | 10.29% | |
| Operating Income | -- | -- | -44.14% | -100.21% | |
| Income Before Tax | -- | -- | -42.30% | -126.80% | |
| Income Tax Expenses | -- | -- | -56.84% | 25.38% | |
| Earnings from Continuing Operations | -- | -- | -41.36% | -125.74% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -41.36% | -125.74% | |
| EBIT | -- | -- | -44.14% | -100.21% | |
| EBITDA | -- | -- | -47.67% | -113.61% | |
| EPS Basic | -- | -- | -22.05% | -65.12% | |
| Normalized Basic EPS | -- | -- | 10.89% | -95.26% | |
| EPS Diluted | -- | -- | -22.09% | -65.12% | |
| Normalized Diluted EPS | -- | -- | 10.89% | -95.26% | |
| Average Basic Shares Outstanding | -- | -- | 16.20% | 15.38% | |
| Average Diluted Shares Outstanding | -- | -- | 16.20% | 15.38% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |